Skip to content

Hematology/Oncology Fellowship (ACGME) - Research & Scholarly Activity

Fellows are expected to engage in scholarly activity as an integral part of their fellowship training. There are over 120 medical oncologists and hematologists in Kaiser Permanente Northern California, many of whom are actively engaged in clinical research. In addition, our medical group is one of the leading enrollers to large NCI-sponsored cooperative group trials in the nation.  There are many opportunities to support your clinical research goals within our program.

Aida Shirazi R.Ph., M.S., Ph.D. Kaiser San Francisco Medical Center Research Project Manager
Dr. Shirazi supports fellows throughout the research process. She guides fellows through the process of IRB training, IRB proposals, and local funding. She collaborates closely with fellows, faculty, and their research team to formalize a research plan, develop research proposals and submit it to the IRB. She also collaborates with research teams to provide guidance on research projects, contributing to research goals, planning, reporting, distribution, and publications.

Kaiser Permanente Oncology Clinical Trials (KPOCT) Program

The KPOCT program is a nationally recognized cancer clinical trials program that enables many oncology patients in the Northern California region to benefit from clinical trials and research studies. KPOCT is a key member in the National Cancer Institute (NCI) Community Oncology Research Program (NCORP).  Nationwide, Kaiser Permanente enrolls one of every 40 patients participating in cancer clinical trials. At any one time, there are over 50 cancer trials open to enrollment.  All members of the oncology faculty in the program are NCI registered clinical trial investigators. In 2014 the NCI awarded the KPOCT program $10.4 million over five years. Hematology-Oncology fellows can enroll patients on KPOCT clinical trials under the supervision of the faculty attending.

Kaiser Permanente Division of Research (DOR)

The KP DOR conducts epidemiological, translational, and health services research, as well as clinical trials. It has over 250 ongoing studies supported by more than $100 million funding per year. Sources of funding include the National Institute of Health, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. The DOR consists of over 600 people, including over 60 investigators. It is located in Oakland and is an integral part of The Permanente Medical Group. For those fellows with an interest in epidemiology, outcomes, and service delivery research, the DOR offers incredible opportunities for education, collaboration, and building a career in those areas.

Additional Sources of research funding for fellows

  • Delivery Science Fellowship and Research
  • Funding through general medical education

Featured Research

First-Year Fellow Michael Lee, MD is the lead author of the study “Trends and disparities in oncology telehealth after the initial pandemic era”.
Read more about his retrospective cohort study of 22 Kaiser Permanente Northern California hematology and oncology clinics on ASCO Daily News.

ASCO Quality Care Conference, Chicago, September 30-October 1, 2022
CCF Merit Awards received for two fellow posters

Back To Top